Multi-Center Study Safety of Adipose Derived Mesenchymal Stem Cells for the Treatment of Multiple Sclerosis

NCT02326935 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

2

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

BIOLOGICAL: Autologous adipose derived mesenchymal cells

Sponsor

American CryoStem Corporation